Genetic polymorphism of S-mephenytoin hydroxylation
- 31 December 1989
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 43 (1), 53-76
- https://doi.org/10.1016/0163-7258(89)90047-8
Abstract
No abstract availableThis publication has 53 references indexed in Scilit:
- Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 S-mephenytoin 4-hydroxylaseBiochemistry, 1988
- Genetic polymorphism of human cytochrome P-450 (S)-mephenytoin 4-hydroxylase. Studies with human autoantibodies suggest a functionally altered cytochrome P-450 isozyme as cause of the genetic deficiencyBiochemistry, 1987
- Purification and characterization of human liver cytochrome P-450-ALCBiochemical and Biophysical Research Communications, 1987
- High-resolution crystal structure of cytochrome P450camJournal of Molecular Biology, 1987
- Cloning and sequence determination of a complementary DNA related to human liver microsomal cytochrome P-450 S-mephenytoin 4-hydroxylaseBiochemistry, 1987
- Immunocytochemical evidence for the maintenance of cytochrome P-450 isozymes, NADPH cytochrome C reductase, and epoxide hydrolase in pure and mixed primary cultures of adult human hepatocytes.Journal of Histochemistry & Cytochemistry, 1986
- Competitive inhibition of sparteine oxidation in human liver by β-adrenoceptor antagonists and other cardiovascular drugsLife Sciences, 1984
- Inhibition of sparteine oxidation in human liver by tricyclic antidepressants and other drugsLife Sciences, 1983
- Some observations on the oxidation phenotype status of Nigerian patients presenting with cancerCancer Letters, 1981
- Differences in anaesthetic properties between the optical antipodes of hexobarbital in the ratLife Sciences, 1966